Related references
Note: Only part of the references are listed.Systemic Lupus Erythematosus (SLE) Responder Index response is associated with global benefit for patients with SLE
R. Furie et al.
LUPUS (2018)
Safety, tolerability and pharmacokinetics of subcutaneous and intravenous anifrolumab in healthy volunteers
Raj Tummala et al.
LUPUS SCIENCE & MEDICINE (2018)
Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
Richard Furie et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Molecular basis for antagonistic activity of anifrolumab, an anti-interferon-alpha receptor 1 antibody
Li Peng et al.
MABS (2015)
Advances in understanding the role of type I interferons in systemic lupus erythematosus
Mary K. Crow
CURRENT OPINION IN RHEUMATOLOGY (2014)
Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus
Zev Sthoeger et al.
JOURNAL OF AUTOIMMUNITY (2014)
Dose-escalation of human anti-interferon-alpha receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study
Avram Goldberg et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Regulation of type I interferon responses
Lionel B. Ivashkiv et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Clinical and serological manifestations associated with interferon-α levels in childhood-onset systemic lupus erythematosus
Mariana Postal et al.
CLINICS (2012)
Network Analysis of Associations Between Serum Interferon-α Activity, Autoantibodies, and Clinical Features in Systemic Lupus Erythematosus
Corinna E. Weckerle et al.
ARTHRITIS AND RHEUMATISM (2011)
The type I interferon system in the etiopathogenesis of autoimmune diseases
Lars Ronnblom
UPSALA JOURNAL OF MEDICAL SCIENCES (2011)
Monitoring systemic lupus erythematosus in standard clinical care
Michelle Petri
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2007)
Elimination mechanisms of therapeutic monoclonal antibodies
MA Tabrizi et al.
DRUG DISCOVERY TODAY (2006)
CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment
A Trotti et al.
SEMINARS IN RADIATION ONCOLOGY (2003)
Pathogenesis of systemic lupus erythematosus
CC Mok et al.
JOURNAL OF CLINICAL PATHOLOGY (2003)
Share Paper
